Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.
Rhythm Pharmaceuticals (RYTM) added ~8% in the premarket on Friday after the U.S. Food and Drug Administration (FDA) approved a label expansion for its lead asset, setmelanotide, to allow its use in ...
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
GSK (GSK) stock is in focus as the U.S. FDA expands authorization for the company's Arexvy RSV vaccine to cover adults 18–49. Read more here.
Although FDA Commissioner Marty Makary promised “an exciting treatment” for autism, what the agency delivered was a label ...
Sarah Todd returned to reporting in January 2025 after being assignment editor at STAT since October 2022. You can reach Sarah on Signal at sarahlizchar.47. A new government proposal to display ...
WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results